Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon May 20, 2022 12:13pm
171 Views
Post# 34698597

RE:RE:SVA POTENTIAL TO HAVE $96 Million in Cash

RE:RE:SVA POTENTIAL TO HAVE $96 Million in CashNothign wrong with having cash on hand but not when it comes with massive dilution. If they could get a proper IR team to start promoting the stock and get the price up to where it deserves to be, they could easily raise more capital with less dilution with strong institutions instead of whoring themselves out to the lowest bidder who ends up abusing sva after blowing their load all over her retailers.




They actually have something to promote now, 3 patients off insulin, deal with Evotec, competition is all failing, fully cashed up, autograft thyroid trial to be started in a few months. The story sounds almost too good to be true and they still can't do anything with it yet they spend so much on IR. 




donkeyfeathers wrote: Here's a consideration SF,
Right now it's the banksters and investment houses (LJ & CC) that are maintaining the rangebound price tag (i.e. between them and the IR guys in house, they have an agenda to short whenever they want). There is so much chatter about institutional investors picking up shares when the uplisting happens, and no doubt there will be SOME interest.  But there's a third leg here: Big pharma could hold 4% of the company without having to make any declarations.  Hypothetically that means a pharma (especially a pharma competitor) could hold...say...10,000,000 shares at any time and use that position to "position themselves" for any kind of outcome they choose to explore.  I know there are folks (retail) who hold what they consider to be large positions, but it would appear that those in the 10 million+ category is small relative to insiders and BD financiers.  When it's going to get interesting, is when (not if) the proxies for EVOTEC decide that they want to duke it out with the range binders.  As the de-risking continues (fingers crossed) it will be harder and harder for the "anonymous" tribe (more than one) to bully the price, should ownership (which now includes EVOTEC...praise the Lord) start to take back control with some of that $90 Million +.  Let's see if Phillip and the board (with our newest board member) are ready to face down the guy(s) who like to throw up a million shares on news, just to pish retail off.  
DF 


<< Previous
Bullboard Posts
Next >>